| Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo … PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ... The Lancet 390 (10105), 1833-1842, 2017 | 1160 | 2017 |
| Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial C Gridelli, F Perrone, C Gallo, S Cigolari, A Rossi, F Piantedosi, ... Journal of the National Cancer Institute 95 (5), 362-372, 2003 | 1069 | 2003 |
| Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy … P Maione, F Perrone, C Gallo, L Manzione, FV Piantedosi, S Barbera, ... Journal of Clinical Oncology 23, 6865-6872, 2005 | 564 | 2005 |
| Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure S George, JY Blay, PG Casali, A Le Cesne, P Stephenson, SE Deprimo, ... European journal of cancer 45 (11), 1959-1968, 2009 | 444 | 2009 |
| Malignant peripheral nerve sheath tumors M Farid, EG Demicco, R Garcia, L Ahn, PR Merola, A Cioffi, RG Maki The oncologist 19 (2), 193-201, 2014 | 357 | 2014 |
| Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial A Le Cesne, I Ray-Coquard, BN Bui, A Adenis, M Rios, F Bertucci, ... The lancet oncology 11 (10), 942-949, 2010 | 348 | 2010 |
| Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes P Schöffski, IL Ray-Coquard, A Cioffi, NB Bui, S Bauer, JT Hartmann, ... The lancet oncology 12 (11), 1045-1052, 2011 | 263* | 2011 |
| Advanced chondrosarcomas: role of chemotherapy and survival A Italiano, O Mir, A Cioffi, E Palmerini, S Piperno-Neumann, C Perrin, ... Annals of oncology 24 (11), 2916-2922, 2013 | 232 | 2013 |
| Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation … P Pautier, A Floquet, N Penel, S Piperno-Neumann, N Isambert, A Rey, ... The oncologist 17 (9), 1213-1220, 2012 | 221 | 2012 |
| Natural killer cell IFN-γ levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor–bearing patients C Ménard, JY Blay, C Borg, S Michiels, F Ghiringhelli, C Robert, C Nonn, ... Cancer research 69 (8), 3563-3569, 2009 | 221 | 2009 |
| Docetaxel and gemcitabine combination in 133 advanced soft‐tissue sarcomas: A retrospective analysis JO Bay, I Ray‐Coquard, J Fayette, S Leyvraz, S Cherix, ... International Journal of Cancer 119 (3), 706-711, 2006 | 215 | 2006 |
| Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer M Di Maio, C Gridelli, C Gallo, L Manzione, L Brancaccio, S Barbera, ... British journal of cancer 90 (12), 2288-2296, 2004 | 186 | 2004 |
| Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas A Italiano, A Cioffi, N Penel, MG Levra, C Delcambre, E Kalbacher, ... Cancer 118 (13), 3330-3336, 2012 | 160 | 2012 |
| Activity and toxicity of gemcitabine and gemcitabine+ vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung … C Gridelli, S Cigolari, C Gallo, L Manzione, GP Ianniello, L Frontini, ... Lung Cancer 31 (2-3), 277-284, 2001 | 156 | 2001 |
| Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival A Italiano, M Toulmonde, A Cioffi, N Penel, N Isambert, E Bompas, ... Annals of Oncology 23 (6), 1601-1607, 2012 | 154 | 2012 |
| Phase II study of oral masitinib mesilate in imatinib-naive patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST) A Le Cesne, JY Blay, BN Bui, O Bouché, A Adenis, J Domont, A Cioffi, ... European Journal of Cancer 46 (8), 1344-1351, 2010 | 149 | 2010 |
| Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors E Palmerini, EL Staals, RG Maki, S Pengo, A Cioffi, M Gambarotti, P Picci, ... European Journal of Cancer 51 (2), 210-217, 2015 | 136 | 2015 |
| Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy PA Zucali, T De Pas, G Palmieri, A Favaretto, A Chella, M Tiseo, M Caruso, ... Journal of Clinical Oncology 36 (4), 342-349, 2018 | 134 | 2018 |
| Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO) C Chevreau, A Le Cesne, I Ray‐Coquard, A Italiano, A Cioffi, N Isambert, ... Cancer 119 (14), 2639-2644, 2013 | 120 | 2013 |
| Treating soft tissue sarcomas with adjuvant chemotherapy A Patrikidou, J Domont, A Cioffi, A Le Cesne Current treatment options in oncology 12, 21-31, 2011 | 83 | 2011 |
